Indian firm to soon launch copycat of anti-breast-cancer drug For Swiss pharma major Roche, not pursuing an Indian patent for its anti-breast-cancer drug, Herceptin, might mean a loss of millions......
India has partly revoked patents granted to Roche Holding AG for its breast cancer drug Herceptin, a spokesman for the drugmaker confirmed on Sunday.Swiss newspaper Schweiz am Sonntag reported that......
Biocon has lashed out at Roche a day after the Swiss company secured an order from the Delhi High Court barring the Indian company from marketing its new drug, co-developed with Mylan, as a......
The government's move to issue compulsory licences for three more patented cancer drugs is a jolt to multinational pharmaceutical companies.The plan is to issue CLs for Trastuzumab (or Herceptin,......